1-hydroxymethylmidazolam has been researched along with tabimorelin in 1 studies
| Studies (1-hydroxymethylmidazolam) | Trials (1-hydroxymethylmidazolam) | Recent Studies (post-2010) (1-hydroxymethylmidazolam) | Studies (tabimorelin) | Trials (tabimorelin) | Recent Studies (post-2010) (tabimorelin) |
|---|---|---|---|---|---|
| 163 | 46 | 49 | 21 | 6 | 1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Christiansen, T; Ilondo, MM; Olsen, AK; Rasmussen, MH; Schulz, R; Taub, ME; Thomsen, MS; Zdravkovic, M | 1 |
1 trial(s) available for 1-hydroxymethylmidazolam and tabimorelin
| Article | Year |
|---|---|
A clinical study investigating the pharmacokinetic interaction between NN703 (tabimorelin), a potential inhibitor of CYP3A4 activity, and midazolam, a CYP3A4 substrate.
Topics: Adjuvants, Anesthesia; Adult; Area Under Curve; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dipeptides; Drug Interactions; Half-Life; Humans; Male; Midazolam; Middle Aged; Time Factors | 2003 |